SK

Shivbabu Kesarwani

Active Director Director DIN 07039923
DIN 07039923 First appointment Mar 2015 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Shivbabu Kesarwani

Data last updated:

Shivbabu Kesarwani is a Director at Kesarwani Drugs Private Limited (since 2015). The company operates in Healthcare.

DIN 07039923
Primary Designation Director
Industry Healthcare
First Appointment 02 Mar 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kesarwani Drugs Private Limited U33111UP2015PTC069291
Director02 Mar 20152015Under Process Of Striking Off

Board colleagues of Shivbabu Kesarwani

Directorship timeline

Open interactive timeline →
Kesarwani Drugs Private Limited
Premium access

Shareholding and investment profile for Shivbabu Kesarwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivbabu Kesarwani

Shivbabu Kesarwani currently holds 1 directorship: Kesarwani Drugs Private Limited (Director, since 02 Mar 2015).

Shivbabu Kesarwani was first appointed on 02 Mar 2015 as Director at Kesarwani Drugs Private Limited.

The current boards of Shivbabu Kesarwani's companies include Devendra Mani Sharma (Kesarwani Drugs Private Limited), Hemshree (Kesarwani Drugs Private Limited), Meena Kesarwani (Kesarwani Drugs Private Limited), Rahul (Kesarwani Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available